Cleared Traditional

K940403 - ELIAS CARDIOLIPIN ANTIBODIES (FDA 510(k) Clearance)

Sep 1994
Decision
236d
Days
Class 2
Risk

K940403 is an FDA 510(k) clearance for the ELIAS CARDIOLIPIN ANTIBODIES. This device is classified as a System, Test, Anticardiolipin Immunological (Class II - Special Controls, product code MID).

Submitted by Elias U.S.A., Inc. (Osceola, US). The FDA issued a Cleared decision on September 20, 1994, 236 days after receiving the submission on January 27, 1994.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K940403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1994
Decision Date September 20, 1994
Days to Decision 236 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MID — System, Test, Anticardiolipin Immunological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660

Similar Devices — MID System, Test, Anticardiolipin Immunological

All 93
Aptiva APS IgG Reagent
K223093 · Inova Diagnostics, Inc. · Dec 2024
ELIA(TM) CARDIOLIPIN IGA IMMUNOASSAY
K131821 · Phadia US, Inc. · Dec 2013
BIOPLEX 2200 APLS IGM
K130528 · Bio-Rad Laboratories · Oct 2013
QUANTA FLASH ACL LGA, QUANTA FLASH B2GP1 IGA
K120817 · Inova Diagnostics, Inc. · Feb 2013
IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISAS
K113020 · Immco Diagnostics, Inc. · Oct 2012
BIOPLEX 2200 APLS IGG AND IGA KIT AND CALIBRATOR AND CONTROL SETS
K103834 · Bio-Rad Laboratories · Mar 2012